Literature DB >> 15886886

Epithelial progenitors in the normal human mammary gland.

John Stingl1, Afshin Raouf, Joanne T Emerman, Connie J Eaves.   

Abstract

The human mammary gland is organized developmentally as a hierarchy of progenitor cells that become progressively restricted in their proliferative abilities and lineage options. Three types of human mammary epithelial cell progenitors are now identified. The first is thought to be a luminal-restricted progenitor; in vitro under conditions that support both luminal and myoepithelial cell differentiation, this cell produces clones of differentiating daughter cells that are exclusively positive for markers characteristic of luminal cells produced in vivo (i.e., keratins 8/18 and 19, epithelial cell adhesion molecule [EpCAM] and MUC1). The second type is a bipotent progenitor. It is identified by its ability to produce "mixed" colonies in single cell assays. These colonies contain a central core of cells expressing luminal markers surrounded by cells with a morphology and markers (e.g., keratin 14(+)) characteristic of myoepithelial cells. Serial passage in vitro of an enriched population of bipotent progenitors promotes the expansion of a third type of progenitor that is thought to be myoepithelial-restricted because it only produces cells with myoepithelial features. Luminal-restricted and bipotent progenitors can prospectively be isolated as distinct subpopulations from freshly dissociated suspensions of normal human mammary cells. Both are distinguished from many other cell types in mammary tissue by their expression of EpCAM and CD49f (alpha6 integrin). They are distinguished from each other by their differential expression of MUC1, which is expressed at much higher levels on the luminal progenitors. To relate the role of these progenitors to the generation of the three-dimensional tubuloalveolar structure of the mammary tree produced in vivo, we propose a model in which the commitment to the luminal versus the myoepithelial lineage may play a determining role in the generation of alveoli and ducts.

Entities:  

Mesh:

Year:  2005        PMID: 15886886     DOI: 10.1007/s10911-005-2540-7

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  78 in total

1.  Immunocytochemical identification of proliferating cell types in mouse mammary gland.

Authors:  A Sapino; L Macrì; P Gugliotta; G Bussolati
Journal:  J Histochem Cytochem       Date:  1990-11       Impact factor: 2.479

2.  Two types of normal human breast epithelial cells derived from reduction mammoplasty: phenotypic characterization and response to SV40 transfection.

Authors:  C Y Kao; K Nomata; C S Oakley; C W Welsch; C C Chang
Journal:  Carcinogenesis       Date:  1995-03       Impact factor: 4.944

3.  Cell proliferation in the human mammary epithelium. Differential contribution by epithelial and myoepithelial cells.

Authors:  K Joshi; J A Smith; N Perusinghe; P Monoghan
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

4.  Subtypes of non-transformed human mammary epithelial cells cultured in vitro: histo-blood group antigen H type 2 defines basal cell-derived cells.

Authors:  U Karsten; G Papsdorf; A Pauly; B Vojtesek; R Moll; E B Lane; H Clausen; P Stosiek; M Kasper
Journal:  Differentiation       Date:  1993-08       Impact factor: 3.880

5.  Antigenic subsets of human breast epithelial cells distinguished by monoclonal antibodies.

Authors:  P A Edwards; I M Brooks
Journal:  J Histochem Cytochem       Date:  1984-05       Impact factor: 2.479

6.  Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle.

Authors:  A Gompel; A Martin; P Simon; D Schoevaert; G Plu-Bureau; D Hugol; J Audouin; E Leygue; J B Truc; P Poitout
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 7.  Human breast cancer cell lines as models of growth regulation and disease progression.

Authors:  S P Ethier
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-01       Impact factor: 2.673

8.  Cell size and shape changes in the myoepithelium of the mammary gland during differentiation.

Authors:  J T Emerman; A W Vogl
Journal:  Anat Rec       Date:  1986-11

9.  Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media.

Authors:  S P Ethier; M L Mahacek; W J Gullick; T S Frank; B L Weber
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

10.  Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition.

Authors:  Thorarinn Gudjonsson; Lone Rønnov-Jessen; René Villadsen; Fritz Rank; Mina J Bissell; Ole William Petersen
Journal:  J Cell Sci       Date:  2002-01-01       Impact factor: 5.285

View more
  63 in total

Review 1.  The molecular pathology of breast cancer progression.

Authors:  Alessandro Bombonati; Dennis C Sgroi
Journal:  J Pathol       Date:  2010-11-16       Impact factor: 7.996

2.  Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds.

Authors:  Junqing Ye; Jian Ge; Xu Zhang; Lin Cheng; Zhengyuan Zhang; Shan He; Yuping Wang; Hua Lin; Weifeng Yang; Junfang Liu; Yang Zhao; Hongkui Deng
Journal:  Cell Res       Date:  2015-12-25       Impact factor: 25.617

3.  Complex display of putative tumor stem cell markers in the NCI60 tumor cell line panel.

Authors:  Christina H Stuelten; Susan D Mertins; Johanna I Busch; Meghan Gowens; Dominic A Scudiero; Mark W Burkett; Karen M Hite; Mike Alley; Melinda Hollingshead; Robert H Shoemaker; John E Niederhuber
Journal:  Stem Cells       Date:  2010-04       Impact factor: 6.277

4.  Nuclear signalling by tumour-associated antigen EpCAM.

Authors:  Dorothea Maetzel; Sabine Denzel; Brigitte Mack; Martin Canis; Philip Went; Michael Benk; Cuong Kieu; Peer Papior; Patrick A Baeuerle; Markus Munz; Olivier Gires
Journal:  Nat Cell Biol       Date:  2009-01-11       Impact factor: 28.824

5.  Lineage-specific markers of goat mammary cells in primary culture.

Authors:  Sonja Prpar Mihevc; Jernej Ogorevc; Peter Dovc
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-09-12       Impact factor: 2.416

6.  Regulation of in situ to invasive breast carcinoma transition.

Authors:  Min Hu; Jun Yao; Danielle K Carroll; Stanislawa Weremowicz; Haiyan Chen; Daniel Carrasco; Andrea Richardson; Shelia Violette; Tatiana Nikolskaya; Yuri Nikolsky; Erica L Bauerlein; William C Hahn; Rebecca S Gelman; Craig Allred; Mina J Bissell; Stuart Schnitt; Kornelia Polyak
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

7.  Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers.

Authors:  Wendy W Hwang-Verslues; Wen-Hung Kuo; Po-Hao Chang; Chi-Chun Pan; Hsing-Hui Wang; Sheng-Ta Tsai; Yung-Ming Jeng; Jin-Yu Shew; John T Kung; Chung-Hsuan Chen; Eva Y-H P Lee; King-Jen Chang; Wen-Hwa Lee
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

8.  Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability.

Authors:  Jennifer H Law; Yvonne Li; Karen To; Michelle Wang; Arezoo Astanehe; Karen Lambie; Jaspreet Dhillon; Steven J M Jones; Martin E Gleave; Connie J Eaves; Sandra E Dunn
Journal:  PLoS One       Date:  2010-09-10       Impact factor: 3.240

9.  Human milk protein production in xenografts of genetically engineered bovine mammary epithelial stem cells.

Authors:  Eugenio Martignani; Peter Eirew; Paolo Accornero; Connie J Eaves; Mario Baratta
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

10.  Characterization of human breast cancer epithelial cells (HBCEC) derived from long term cultured biopsies.

Authors:  Ralf Hass; Catharina Bertram
Journal:  J Exp Clin Cancer Res       Date:  2009-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.